Spinout Portfolio

Spinout Companies - Opportunities for Investment and Partnerships

Since 2001, hundreds of  new companies have been set up based on research from the universities in the MICRA partnership. This has created thousands of jobs and attracted many millions of pounds in investment.

A key part of the MICRA programme is to continue this important work by supporting research projects to a stage where they have an investment-ready product or service to offer. Alongside this we are showcasing the companies in a series of events and activities to offer investors and commercial partners the opportunity to get involved with some of the most exciting developments to come out of the UK today.

A selection of our spin-out companies is shown below. To find out more, click on the profiles below to visit their website, or get in touch with us:

Please also read the Important Information at the foot of this page.

Engineering, Materials & Manufacturing

Corrosion Radar logo


The worlds longest range Corrosion Under Insulation (CUI) monitoring technology for pipelines, refineries and more for predictive corrosion management


Drone-in-a-box technology allows industry to deploy and maintain drone operations from anywhere in the world without the need for a pilot onsite.

Vanguard STS

Design, building and development of HydroFLEX, the U.K.'s first hydrogen train., and developing hydrogen refuelling infrastructure.

HALO X-ray Technologies

Next generation X-ray technology - new materials detection capability, protecting people and infrastructure, enhancing process control in manufacturing

Texturejet logo


Innovative Surface Texture Adjustment Technology (STAT) redefines surface texture simply and cleanly resulting in streamlined production lines.


Wire-based Additive Manufacturing - highly accurate, cost-effective and environmentally-friendly manufacturing for aerospace and other industries.

Aston Particle Technologies

A one-step particle engineering technology, delivering enhanced particle properties for challenging drugs without compromising their innate properties.

Promethean Particles logo

Promethean Particles

Development and manufacture of nanoparticle dispersions in the world’s largest continuous nanoparticle manufacturing plant

Warwick Acoustics

Designing and manufacturing the lightest, most power-efficient and sustainable ElectroAcoustic Panel for the vehicles of the future.

Interface Polymers

An additive technology to improve cost and performance characteristics of polyolefins, and create new recyclable polymer packaging.

Stoli Catalysts

A transformative technology - catalyst-coated tubes for continuous flow reactors for more efficient manufacturing of fine chemicals


Chemical-free disinfection of agricultural seeds increases agricultural yield and kills bacteria and fungi without killing the seeds

Artificial Intelligence & Data


Air quality sensors and advanced pollution modelling and API, products to enable visualisation and management of air quality.

Grid Edge

Cloud-based AI software services to empower building operators to predict, optimise and control their energy profile.

BlueSkeye AI

Ethical AI for the analysis of medically relevant expressive behaviour - mobile device apps for mental health monitoring.

Footfalls & Heartbeats

Smart textile technology using electrically conductive yarn to form a repeatable and robust sensor network to allow real-time monitoring.

Spectra analytics logo

Spectra Analytics

Data Science and AI solutions across a broad range of industries which empower businesses by generating actionable insights from their data.


A global provider of real-time, street level flood prediction and analytical solutions, building resilience, saving lives and livelihoods.

Diagnostic & MedTech

4D Biomaterials

A new class of biocompatible, resorbable 3D printing materials for implants and other biomedical applications.

Locate Bio

Orthobiologics company developing products that improve the lives of people with debilitating orthopaedic conditions.


Exploiting the therapeutic potential of PEPITEM, a novel peptide which controls inflammation in a range of chronic inflammatory diseases.


Developing protein nanosyringes which deliver bioactive proteins and peptides through cell membranes for precision intracellular targeting.


BioEp is a seizure susceptibility assessment technology enabling faster and more accurate diagnosis and prognosis of epilepsy.

SurePulse Medical

Wireless heart rate monitors designed specifically for the one in ten babies needing stabilisation or resuscitation at delivery.

Linear Diagnostics logo

Linear Diagnostics

Portable, rapid diagnostic platform technology using linear dichroism (LD) can check for multiple targets and types of targets in the same test at the same time.

MIP Diagnostics logo

MIP Diagnostics

Creating nanoMIPs - versatile, robust and highly stable, affinity reagent solutions where antibodies have reached their performance limit.

PBD Biotech

PBD Biotech

Actiphage® is a highly sensitive test for mycobacterial diseases such as Tuberculosis and bovine TB and detects infection in blood or milk within six hours.


A portable device for on-the-spot detection and identification of live bacteria in water and other critical environments, all within minutes.

Exonate logo


Revolutionary eye drop treatment for retinal vascular diseases, including wet Age-Related Macular Degeneration and Diabetic Macular Oedema

Medherant logo


TEPI Patch® is a new transdermal drug delivery system which offers greater convenience, confidence and comfort for patient and better dose control

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Midlands Innovation Commercialisation of Research Accelerator (MICRA) does not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Close Menu

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.